logo
Share SHARE
FONT-SIZE Plus   Neg

Teva Commences Launch Of Irbesartan And Irbesartan-hydrochlorothiazide Tablets

Generic drugmaker Teva Pharmaceutical Industries Ltd. (TEVA) Monday said it has commenced commercial launch of both irbesartan and irbesartan-hydrochlorothiazide tablets, the company's generic versions of Sanofi Aventis' high blood pressure treatments, Avapro and Avalide tablets.

The brand products had annual sales of around $464 million and $124 million, respectively, in the U.S., based on IMS sales data.

As the first company to file Abbreviated New Drug Applications containing paragraph IV certifications for both of these products, Teva has been awarded a 180-day period of marketing exclusivity.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
UPS (UPS) has announced the expansion of its UPS Worldwide Express package service to reach 117 countries and territories. UPS, the world's largest package delivery services, delivers more packages internationally than any other carrier. Over 50 countries and territories have been added to the UPS... Air France cabin crew, represented by the SNPNC-FO and UNSA-PNC unions, have announced their plan to go on strike from July 27 to August 2. The strike is for a new labor agreement as well as to increase number of crew members and for better working conditions. Air France expects the strike to... Apple typically schedules its iPhone launch event in September every year. However, the tech giant has not made any official announcement about the new iPhone 7 event date yet. According to popular and reliable leaker Evan Blass, Apple will ship iPhone 7 during "the week of September 12." He later...
comments powered by Disqus
Follow RTT